Perry Nisen

Perry Nisen is an American physician and the former chief executive officer (CEO) of the Sanford Burnham Prebys Medical Discovery Institute (SBP). He was appointed as CEO in August 2014, and held the Donald Bren Chief Executive Chair.

Early life and education

 * B.S. from Stanford University
 * M.D. and Ph.D. from the Albert Einstein College of Medicine
 * Residency, Columbia University College of Physicians and Surgeons

Career
Before joining SBP, Nisen was Senior Vice President of Science and Innovation at GlaxoSmithKline (GSK). In this role, he facilitated innovation and integration of R&D across GSK's global organization and contributed to the discovery, development and commercialization of many drugs. Earlier in his career at GSK, he held various key positions, including interim Chief Medical Officer, Senior Vice President and Oncology Therapy Area Head, Senior Vice President of Cancer Research, and Senior Vice President of Clinical Pharmacology and Discovery Medicine.

Formerly, he was the Lowe Foundation Professor of Neuro-Oncology at the University of Texas Southwestern Medical Center. He headed a basic research laboratory and was a practicing physician in pediatric hematology-oncology. He was a member of the Genetics and Development Graduate Training Program.

Awards and honors

 * Alpha Omega Alpha
 * Macintosh Fellowship, Columbia University College of Physicians and Surgeons
 * Basil O'Connor Research Award of the March of Dimes
 * Lowe Foundation Professorship UT Southwestern
 * Woodward Visiting Scholar, Harvard University